GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chiome Bioscience Inc (TSE:4583) » Definitions » E10

Chiome Bioscience (TSE:4583) E10 : 円-46.83 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Chiome Bioscience E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Chiome Bioscience's adjusted earnings per share data for the three months ended in Mar. 2024 was 円-5.600. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is 円-46.83 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-20), Chiome Bioscience's current stock price is 円129.00. Chiome Bioscience's E10 for the quarter that ended in Mar. 2024 was 円-46.83. Chiome Bioscience's Shiller PE Ratio of today is .


Chiome Bioscience E10 Historical Data

The historical data trend for Chiome Bioscience's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chiome Bioscience E10 Chart

Chiome Bioscience Annual Data
Trend Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -45.48 -47.54 -47.53

Chiome Bioscience Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -47.44 -47.46 -47.67 -47.53 -46.83

Competitive Comparison of Chiome Bioscience's E10

For the Biotechnology subindustry, Chiome Bioscience's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chiome Bioscience's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chiome Bioscience's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Chiome Bioscience's Shiller PE Ratio falls into.



Chiome Bioscience E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chiome Bioscience's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-5.6/107.2000*107.2000
=-5.600

Current CPI (Mar. 2024) = 107.2000.

Chiome Bioscience Quarterly Data

per share eps CPI Adj_EPS
201406 -13.270 98.000 -14.516
201409 -14.280 98.500 -15.541
201412 -15.900 97.900 -17.410
201503 -15.920 97.900 -17.432
201506 -16.010 98.400 -17.442
201509 -11.263 98.500 -12.258
201512 -15.110 98.100 -16.512
201603 -13.620 97.900 -14.914
201606 -18.370 98.100 -20.074
201609 -11.250 98.000 -12.306
201612 -22.670 98.400 -24.697
201703 -7.930 98.100 -8.666
201706 -7.090 98.500 -7.716
201709 -6.910 98.800 -7.497
201712 -11.560 99.400 -12.467
201803 -11.250 99.200 -12.157
201806 -11.303 99.200 -12.215
201809 -12.080 99.900 -12.963
201812 -22.632 99.700 -24.335
201903 -15.590 99.700 -16.763
201906 -9.955 99.800 -10.693
201909 -12.430 100.100 -13.312
201912 -7.019 100.500 -7.487
202003 -12.780 100.300 -13.659
202006 -9.230 99.900 -9.904
202009 -9.320 99.900 -10.001
202012 -5.212 99.300 -5.627
202103 -4.000 99.900 -4.292
202106 -6.160 99.500 -6.637
202109 -10.780 100.100 -11.545
202112 -15.800 100.100 -16.921
202203 -11.660 101.100 -12.364
202206 -6.510 101.800 -6.855
202209 -5.700 103.100 -5.927
202212 -4.446 104.100 -4.578
202303 -4.700 104.400 -4.826
202306 -9.000 105.200 -9.171
202309 -5.120 106.200 -5.168
202312 -5.800 106.800 -5.822
202403 -5.600 107.200 -5.600

Add all the adjusted EPS together and divide 10 will get our e10.


Chiome Bioscience  (TSE:4583) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Chiome Bioscience E10 Related Terms

Thank you for viewing the detailed overview of Chiome Bioscience's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Chiome Bioscience (TSE:4583) Business Description

Traded in Other Exchanges
N/A
Address
Sumitomo Fudosan Nishi-shinjuku Building No.6, 3-12-1, Honmachi, Shibuya-ku, Tokyo, JPN, 151-0071
Chiome Bioscience Inc is a Japanese based company engaged in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library System. The business activity of the group is operated through Drug Discovery Alliance, Lead Antibody Licensing, and Licensing Out Platform Technology segments. The Drug Discovery Alliance segment partners with pharmaceutical companies to develop and create lead antibody drugs. The Lead Antibody Licensing Out segment is engaged in the production of specific antibodies against antigens and early licensing out to pharmaceutical manufacturers and the Licensing Out Platform Technology segment conducts research and development through the ADLib System. Geographically all the activities are functioned through Japan.

Chiome Bioscience (TSE:4583) Headlines

No Headlines